Stocks of Relay Therapeutics Inc (NASDAQ:RLAY) traded higher last session on Wall Street, down -5.36% to $9.00.
RLAY stock price is now 21.52% away from the 50-day moving average and 9.32% away from the 200-day moving average. The market capitalization of the company currently stands at $1.21B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $10.60 to $16, Jefferies Upgraded its rating from Hold to Buy for Relay Therapeutics Inc (NASDAQ: RLAY). , while ‘Oppenheimer’ rates the stock as ‘Perform’
In other news, Catinazzo Thomas, Chief Financial Officer sold 10,780 shares of the company’s stock on Jul 29 ’24. The stock was sold for $92,316 at an average price of $8.56. Upon completion of the transaction, the Chief Financial Officer now directly owns 319,650 shares in the company, valued at $2.88 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 30 ’24, Rahmer Peter sold 15,128 shares of the business’s stock. A total of $125,260 was realized by selling the stock at an average price of $8.28. This leaves the insider owning 405,637 shares of the company worth $3.65 million. A total of 31.50% of the company’s stock is owned by insiders.
During the past 12 months, Relay Therapeutics Inc has had a low of $5.70 and a high of $12.14. As of last week, the company has a debt-to-equity ratio of 0.07, a current ratio of 15.64, and a quick ratio of 15.64. The fifty day moving average price for RLAY is $7.4557 and a two-hundred day moving average price translates $8.237675 for the stock.
The latest earnings results from Relay Therapeutics Inc (NASDAQ: RLAY) was released for 2024-06-30. The net profit margin was -916.89% and return on equity was -43.28% for RLAY.
